Novo Nordisk saw a big jump in Ozempic sales in India. The company is selling more of its semaglutide weight-loss drug in that market.

• •Novo Nordisk reported a surge in Ozempic sales in India
• •Growth is tied to its semaglutide franchise in the Indian market

Novo Nordisk cut prices on Wegovy and Ozempic in India and saw sales jump 40% in April. The price cuts made the weight-loss and diabetes drugs more affordable in that market.

• •Novo Nordisk India sales rose 40% in April
• •Growth followed price cuts on Wegovy and Ozempic
• •Price cuts applied in the India market

Amazon will start selling Novo Nordisk's Ozempic pill (the tablet form of semaglutide) with same-day delivery and through kiosks. This makes the weight-loss drug easier for patients to get quickly without visiting a traditional pharmacy.

• •Amazon will sell Novo Nordisk's Ozempic pill with same-day delivery
• •The drug will also be available through kiosks
• •Ozempic pill is the tablet form of semaglutide

Novo Nordisk's pill version of Ozempic (semaglutide) is now available in the U.S. for type 2 diabetes. This is the oral form of the drug, which was previously only sold as an injection.

• •Novo Nordisk's oral semaglutide is now available in the U.S.
• •The pill is approved for type 2 diabetes
• •Ozempic was previously sold only as an injection

Novo Nordisk is renaming its pill version of semaglutide from Rybelsus to Ozempic Pills in the United States. The rebrand makes the product name match the company's popular injection version, which could help patients recognize and choose it.

• •Novo Nordisk is renaming Rybelsus to Ozempic Pills in the US
• •The pill contains the same drug as Ozempic, semaglutide
• •The new name matches the well-known injection brand

Novo Nordisk is cutting the official prices it charges for Ozempic and Wegovy in the US by up to half. The price cuts apply to the list prices that insurance companies and pharmacies use to set what patients pay.

• •Novo Nordisk is cutting US list prices for Ozempic and Wegovy
• •Price cuts go up to 50%
• •Cuts apply to list prices used by insurers and pharmacies

Novo Nordisk rebranded its pill form of semaglutide, calling it the Ozempic pill instead of Rybelsus. Amgen cut back some of its drug projects.

• •Novo Nordisk renamed Rybelsus as the Ozempic pill
• •Rybelsus is the pill form of semaglutide
• •Amgen cut back some drug projects in its pipeline

Novo Nordisk is preparing to launch the pill version of Ozempic in the U.S. This is a new way to take the weight-loss and diabetes drug that many people currently get as a weekly injection.

• •Novo Nordisk is getting ready to launch a pill version of Ozempic in the US
• •Most people now take Ozempic as a weekly shot

Novo Nordisk stopped selling Rybelsus, its pill form of semaglutide, in the US. The company is now marketing the same drug under the Ozempic brand name instead.

• •Novo Nordisk stopped selling Rybelsus in the US
• •The oral semaglutide pill will now be sold under the Ozempic brand

Novo Nordisk is expanding its GLP-1 drug portfolio by pushing the pill version of Ozempic and developing treatments for children. The moves aim to reach more patients who want to use the weight-loss and diabetes drug.

• •Novo Nordisk is pushing the pill form of Ozempic
• •Novo is developing GLP-1 treatments for children
• •Moves aim to expand the GLP-1 patient base

A study found that semaglutide, the active ingredient in Ozempic and Wegovy, may help treat alcohol use disorder in people with obesity. The research is still early, but it suggests the drug might work for both weight loss and reducing alcohol use.

• •Study suggests semaglutide may help treat alcohol use disorder in people with obesity
• •Semaglutide is the active ingredient in Ozempic and Wegovy
• •Findings are early-stage

Health Canada approved the first generic copy of semaglutide (Ozempic), Novo Nordisk's diabetes and weight-loss drug. Generic versions are usually cheaper than brand-name drugs, so this approval could give more patients affordable access.

• •Health Canada approved the first generic version of semaglutide (Ozempic)
• •Ozempic is Novo Nordisk's diabetes and weight-loss drug
• •Generic copies are usually cheaper than the brand-name drug